Female pharmacist holding medicines

Government deal to save NHS billions

The Department for Health and Social Care has announced a new landmark deal to save the NHS billions of pounds over the course of five years.

Through the voluntary scheme for branded medicines pricing, access and growth, the NHS can save £14 billion in medicine costs across the five-year period that the agreement will run. This will also support patients to access lifesaving treatments more consistently, as well as solidifying the UK’s position as an advanced healthcare superpower.

Additional funding worth £400 million from the life sciences industry will also help to speed up work on health technology, manufacturing, and clinical trials as this contributes to growth across the economy, as well as innovation and collaboration across the sector.

Victoria Atkins, Health and Social Care Secretary, said:

“Millions of NHS patients will benefit from this momentous, UK-wide agreement.

“Not only will it save the health service billions of pounds every year, it will allow more patients to quickly access the latest life-saving medicines and treatments.

“This deal will also ensure the UK remains a world leader in driving forward innovative healthcare while boosting our economy, with hundreds of millions of pounds invested in vital research, clinical trials and manufacturing.”

With medicines comprising the second highest proportion of NHS spending, £14 billion of the £19.2 billion that was spent on medicines were branded. This has led to the government using the agreement to set a yearly cap on the total allowed sales value of branded medicines to the NHS, with sales that go above the cap being paid back to the government through a new levy.

As the agreement comes into effect next year, £400 million will be invested into the Life Sciences Investment Programme from the pharmaceutical industry to help drive innovation, sustainability, and growth in the UK health sector. This funding will be ringfenced, with support contributing to:

  • Pioneering clinical trials
  • Manufacturing
  • Innovative health technology assessments

These goals will work to improve the NHS’ capacity for commercial clinical research, improve the UK’s standing in sustainable manufacturing, and support innovative medicines.

Medicine - health and social care quote (1)

NHS England’s Director of Medicines Negotiation and Managed Access, who led day-to-day negotiations, Robert Kettell, added:

“This 5-year agreement will enable NHS England to build on our track record of securing innovative, life-changing treatments for millions of patients across the country at a fair price for taxpayers.

“In leading the negotiations, I was clear that any deal had to enable patients to have rapid access to cutting-edge medicines and incentivise the medical research that will provide the treatments of tomorrow. I am confident this agreement delivers these aims.”


Image credit: iStock

NHE Nov/Dec 2023

NHE Nov/Dec 2023

AI is key in helping dementia patients live independently for longer.

The Nov/Dec 2023 edition of NHE brings you expert comment and analysis on a range of key health sector topics, from digital transformation to navigating post-pandemic challenges.


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

National Health Executive Podcast

Ep 39.
What makes a good NHS manager? with Anthony Painter, Director of Policy at Chartered Management Institute (CMI)

In episode 39 of the National Health Executive podcast, we were joined by Anthony Painter, who is the director of policy at the Chartered Management Institute (CMI), to discuss all things management within the UK health sector and NHS.

During the podcast, Anthony shared some of the recent research CMI conducted in partnership with the Social Market Foundation, which centred around the state of management and leadership within the NHS.

More articles...

View all